Dataset from ONO-4538 Phase III Study A Multicenter, Randomized, Open-label Study in Patients With Esophageal Cancer Refractory or Intolerant to Combination Therapy With Fluoropyrimidine and Platinum-based Drugs
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://doi.org/10.25934/PR00009925
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of study is to evaluate the efficacy and safety of Nivolumab in unresectable
advanced or recurrent esophageal cancer patients who have failed in standard chemotherapies.
创建时间：
2026-04-05
